Newsroom: Top News Top News | All News Allarity Therapeutics to Present Trial-in-Progress Poster on Phase 2 Stenoparib Trial at ESMO Gynaecological Cancers Congress 2026 Jun 18, 2026 Read More Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers May 15, 2026 Read More Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm May 08, 2026 Read More